Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reported $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Janssen representative Michelle Bauer said Monday that the settlement isn’t an admission of liability.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
St. Pete Mayor Accepts $275M Bid to Redevelop Tropicana Field Area for Housing 
Florida Supreme Court Ruling Could Mean New Pressure to Settle High-Dollar Lawsuits 
Cedents Find Competitive Market Conditions at Midyear Reinsurance Renewals: Brokers 
A Super Yacht Armada Came to Miami, Leaving a Marine Graveyard in Its Wake 
